Ares Capital (ARCC)
(Real Time Quote from BATS)
$20.76 USD
+0.15 (0.73%)
Updated Sep 23, 2024 12:10 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
ARCC 20.76 +0.15(0.73%)
Will ARCC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ARCC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ARCC
Here is What to Know Beyond Why Ares Capital Corporation (ARCC) is a Trending Stock
Is Ares Capital (ARCC) a Buy as Wall Street Analysts Look Optimistic?
ARCC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ares Capital (ARCC) Stock Drops Despite Market Gains: Important Facts to Note
Ares Capital (ARCC) Stock Declines While Market Improves: Some Information for Investors
Ares Capital (ARCC) Advances But Underperforms Market: Key Facts
Other News for ARCC
Pivotal Moment For BDC Dividend Investors, Here Is What To Do
The High Yield Desert
Ares Capital: How Safe Is This 9.4% Yield?
An Important Warning For Dividend Investors After The Fed's Big Rate Cut
How financial stocks may fare in a ‘game of regulatory seats’ under a Trump White House